Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Know Labs ( (KNW) ) just unveiled an update.
On June 2, 2025, Know Labs, Inc. entered into a Promissory Note Conversion Agreement with J3E2A2Z LP, an entity affiliated with CEO Ronald P. Erickson, to convert approximately $1.18 million in debt into shares of a newly created Series H Convertible Preferred Stock. This strategic move, approved by the Board of Directors on May 30, 2025, is part of the company’s efforts to manage its financial obligations and enhance its capital structure. The issuance of Series H Convertible Preferred Stock, which ranks junior to Series C and D but senior to common stock, is exempt from registration under the Securities Act and includes various rights and conversion options designed to protect the interests of the stakeholders involved.
Spark’s Take on KNW Stock
According to Spark, TipRanks’ AI Analyst, KNW is a Underperform.
Know Labs faces significant financial and operational challenges, reflected in a low overall score. Key factors include negative financial performance due to substantial losses and high leverage, alongside weak technical indicators. Valuation metrics further underscore the stock’s unattractiveness given its negative P/E ratio and absence of dividends. Without any positive earnings call or corporate events to offset these issues, the stock remains a high-risk investment at this time.
To see Spark’s full report on KNW stock, click here.
More about Know Labs
Know Labs, Inc. operates in the technology industry, focusing on developing innovative products and services, though specific market focus details are not provided in the release.
Average Trading Volume: 933,302
Technical Sentiment Signal: Sell
Current Market Cap: $3.65M
Learn more about KNW stock on TipRanks’ Stock Analysis page.